7004 ORAL Pain Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab Vs Zoledronic Acid (ZA) in Patients With Solid Tumours and Bone Metastases

2011 ◽  
Vol 47 ◽  
pp. S485
Author(s):  
L. Fallowfield ◽  
R. von Moos ◽  
D. Patrick ◽  
C.S. Cleeland ◽  
D.H. Henry ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Solid Tumours ◽  
Phase 3 ◽  
Oral Pain ◽  
Pain Outcomes

scholarly journals Pain Interference Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab vs Zoledronic Acid (ZA) in Patients with Solid Tumors and Bone Metastases

2012 ◽  
Vol 23 ◽  
pp. ix509-ix510
Author(s):  
C. Cleeland ◽  
L. Fallowfield ◽  
R. von Moos ◽  
D. Patrick ◽  
D.H. Henry ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Solid Tumors ◽  
Pain Interference ◽  
Phase 3

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

Bone ◽  
2010 ◽  
Vol 46 ◽  
pp. S36-S37 ◽  
Author(s):  
Jean-Jacques Body ◽  
Alison Stopeck ◽  
Yasuhiro Fujiwara ◽  
Allan Lipton ◽  
Guenther Steger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Phase 3 ◽  
Double Blind

A prospective randomized controlled clinical trial of zoledronic acid for bone metastases

2006 ◽  
Vol 23 (1) ◽  
pp. 41-50 ◽  
Author(s):  
Kyriaki Mystakidou ◽  
Emmanuela Katsouda ◽  
Efi Parpa ◽  
Evangelia Kouskouni ◽  
Costas Chondros ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document